{
    "Trade/Device Name(s)": [
        "ADVIA Chemistry Carbon Dioxide Liquid (CO2_L) Assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K100289",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042362"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHS"
    ],
    "Summary Letter Date": "April 1, 2010",
    "Summary Letter Received Date": "April 2, 2010",
    "Submission Date": "May 6, 2010",
    "Regulation Number(s)": [
        "21CFR862.1160"
    ],
    "Regulation Name(s)": [
        "Bicarbonate/carbon dioxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Carbon dioxide"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Chemistry systems",
        "ADVIA 1650 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Absorbance measurement at 410/478 nm"
    ],
    "Methodologies": [
        "Enzymatic quantitation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Chemistry Carbon Dioxide Liquid (CO2_L) Assay for in vitro quantitative measurement of carbon dioxide in human serum and plasma using enzymatic methodology",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of carbon dioxide in human serum and plasma on ADVIA Chemistry Systems to aid in the diagnosis and treatment of disorders associated with changes in acid-base balance",
    "fda_folder": "Clinical Chemistry"
}